Major Breakthrough as Johnson & Johnson Drops Patents, Paving Way for Affordable TB Treatment
In a significant development, Johnson & Johnson (J&J) has announced the relinquishment of its secondary patents on a crucial TB medicine, marking a pivotal moment in the fight against tuberculosis. This decision by J&J opens the door for additional drug manufacturers to produce more affordable generic versions of the medication, offering hope to countless individuals…